Drug Resistance, Multiple, Bacterial
"Drug Resistance, Multiple, Bacterial" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The ability of bacteria to resist or to become tolerant to several structurally and functionally distinct drugs simultaneously. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS).
MeSH Number(s)
G06.099.225.812
G06.225.347.812
G07.690.320.269.347.812
G07.690.320.300.500
Below are MeSH descriptors whose meaning is more general than "Drug Resistance, Multiple, Bacterial".
- Biological Sciences [G]
- Microbiological Phenomena [G06]
- Bacterial Physiological Phenomena [G06.099]
- Drug Resistance, Bacterial [G06.099.225]
- Drug Resistance, Multiple, Bacterial [G06.099.225.812]
- Drug Resistance, Microbial [G06.225]
- Drug Resistance, Bacterial [G06.225.347]
- Drug Resistance, Multiple, Bacterial [G06.225.347.812]
- Physiological Phenomena [G07]
- Pharmacological Phenomena [G07.690]
- Drug Resistance [G07.690.320]
- Drug Resistance, Microbial [G07.690.320.269]
- Drug Resistance, Bacterial [G07.690.320.269.347]
- Drug Resistance, Multiple, Bacterial [G07.690.320.269.347.812]
- Drug Resistance, Multiple [G07.690.320.300]
- Drug Resistance, Multiple, Bacterial [G07.690.320.300.500]
Below are MeSH descriptors whose meaning is more specific than "Drug Resistance, Multiple, Bacterial".
This graph shows the total number of publications written about "Drug Resistance, Multiple, Bacterial" by people in Harvard Catalyst Profiles by year, and whether "Drug Resistance, Multiple, Bacterial" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2000 | 1 | 0 | 1 |
2001 | 0 | 1 | 1 |
2002 | 3 | 0 | 3 |
2003 | 3 | 6 | 9 |
2004 | 6 | 3 | 9 |
2005 | 6 | 6 | 12 |
2006 | 10 | 4 | 14 |
2007 | 8 | 8 | 16 |
2008 | 10 | 5 | 15 |
2009 | 12 | 5 | 17 |
2010 | 10 | 8 | 18 |
2011 | 11 | 9 | 20 |
2012 | 8 | 8 | 16 |
2013 | 10 | 9 | 19 |
2014 | 11 | 7 | 18 |
2015 | 15 | 7 | 22 |
2016 | 18 | 10 | 28 |
2017 | 14 | 13 | 27 |
2018 | 12 | 14 | 26 |
2019 | 26 | 15 | 41 |
2020 | 10 | 9 | 19 |
2021 | 6 | 13 | 19 |
2022 | 0 | 7 | 7 |
2023 | 0 | 3 | 3 |
2024 | 0 | 1 | 1 |
Below are the most recent publications written about "Drug Resistance, Multiple, Bacterial" by people in Profiles.
-
A novel antibiotic class targeting the lipopolysaccharide transporter. Nature. 2024 Jan; 625(7995):566-571.
-
Ceftriaxone-resistant Salmonella Typhi isolated from paediatric patients in north India: Insights into genetic profiles and antibiotic resistance mechanisms. Indian J Med Microbiol. 2023 Nov-Dec; 46:100448.
-
Deep learning-guided discovery of an antibiotic targeting Acinetobacter baumannii. Nat Chem Biol. 2023 Nov; 19(11):1342-1350.
-
Clinical predictors of mortality in patients with pseudomonas aeruginosa infection. PLoS One. 2023; 18(4):e0282276.
-
Polyaspartate-derived synthetic antimicrobial polymer enhances the activity of rifampicin against multidrug-resistant Pseudomonas aeruginosa infections. Biomater Sci. 2022 Sep 13; 10(18):5158-5171.
-
Destroyed left lung due to multidrug-resistant Mycobacterium tuberculosis. Lancet Infect Dis. 2022 08; 22(8):1252.
-
Immunosuppression broadens evolutionary pathways to drug resistance and treatment failure during Acinetobacter baumannii pneumonia in mice. Nat Microbiol. 2022 06; 7(6):796-809.
-
The Phenylacetic Acid Catabolic Pathway Regulates Antibiotic and Oxidative Stress Responses in Acinetobacter. mBio. 2022 06 28; 13(3):e0186321.
-
Phylogeography and transmission of M. tuberculosis in Moldova: A prospective genomic analysis. PLoS Med. 2022 02; 19(2):e1003933.
-
Colistin disposition in the cerebrospinal fluid when administered either intravenously alone or with intraventricular/intrathecally in neonates/pediatric patients with culture-proven meningitis. Pediatr Neonatol. 2022 03; 63(2):190-191.